Received May 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Knees have been excruciatingly painful and are getting worse; The soft tissue around knees has been affected; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knees have been excruciatingly painful and are getting worse) in a patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form and dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Knees have been excruciatingly painful and are getting worse) (seriousness criterion medically significant) and SOFT TISSUE DISORDER (The soft tissue around knees has been affected). At the time of the report, ARTHRALGIA (Knees have been excruciatingly painful and are getting worse) and SOFT TISSUE DISORDER (The soft tissue around knees has been affected) had not resolved. No concomitant medications provided by the reporter. The patient received three moderna covid-19 vaccine. It was reported that, following vaccination, the patient's knees became excruciatingly painful and continued to worsen. It was reported that the soft tissue around the knees was affected for the patient. Consequently, the patient was no longer able to stand to cook, cleaned, took out garbage and recycling, or walked on a regular basis due to the severe pain. It was unknown if the patient experienced any additional symptoms/events. No treatment medications provided by the reporter.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.